They note that the speed and extent of weight loss can vary significantly from person to person, influenced by factors such as initial weight, adherence to the treatment plan, dietary habits, and physical activity levels
Clinical studies, including the STEP (Semaglutide Glp-1 Treatment Effect in People with Obesity) program, have shown that users can lose around 15% of their body weight over 68 weeks, with some achieving even greater results
Available only after consultation with a licensed clinician
The lunch meal alone showed approximately 35% lower energy intake
California has among the most comprehensive telehealth regulations in the country, governed by the Telehealth Advancement Act and overseen by the DMHC and CDPH
Because tirzepatide activates GIP receptors in addition to GLP-1 receptors, you get an entirely separate signaling pathway